|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Catalyst Pharmaceutical Partners, Inc. (CPRX) |
|
|
$20.84 0.00 (0.00%) as of 4:30 Thu 10/2
|
|
Download |
|
|
|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
103,650,000 |
Market
Cap: |
2.16(B) |
Last
Volume: |
1,524,976 |
Avg
Vol: |
1,557,291 |
52
Week Range: |
$19.13 - $26.31 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1161 |
Guru Rank Value : 0 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
243,970 |
761,894 |
2,011,048 |
2,726,303 |
Total Sell Value |
$4,927,241 |
$17,764,148 |
$45,882,504 |
$57,820,887 |
Total People Sold |
4 |
7 |
9 |
10 |
Total Sell Transactions |
6 |
13 |
28 |
44 |
End Date |
2025-07-06 |
2025-04-04 |
2024-10-04 |
2023-10-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Elsbernd Brian |
Chief Compliance/Legal Officer |
|
2025-09-08 |
4 |
S |
$20.30 |
$609,000 |
D/D |
(30,000) |
271,039 |
|
-4% |
|
Elsbernd Brian |
Chief Compliance/Legal Officer |
|
2025-09-08 |
4 |
OE |
$2.24 |
$251,944 |
D/D |
112,475 |
301,039 |
|
- |
|
Elsbernd Brian |
Chief Compliance/Legal Officer |
|
2025-09-04 |
4 |
S |
$19.52 |
$585,600 |
D/D |
(30,000) |
188,564 |
|
-5% |
|
Elsbernd Brian |
Chief Compliance/Legal Officer |
|
2025-09-04 |
4 |
OE |
$2.24 |
$67,200 |
D/D |
30,000 |
218,564 |
|
- |
|
Elsbernd Brian |
Chief Compliance/Legal Officer |
|
2025-09-03 |
4 |
S |
$20.08 |
$401,600 |
D/D |
(20,000) |
188,564 |
|
-5% |
|
Elsbernd Brian |
Chief Compliance/Legal Officer |
|
2025-09-03 |
4 |
OE |
$2.24 |
$44,800 |
D/D |
20,000 |
208,564 |
|
- |
|
Tierney David S |
Director |
|
2025-08-27 |
4 |
S |
$20.20 |
$525,200 |
D/D |
(26,000) |
379,620 |
|
-3% |
|
Tierney David S |
Director |
|
2025-08-27 |
4 |
OE |
$2.24 |
$112,000 |
D/D |
50,000 |
405,620 |
|
- |
|
Miller Steve |
Chief Op. & Scientific Officer |
|
2025-08-27 |
4 |
OE |
$2.24 |
$246,400 |
D/D |
110,000 |
1,059,663 |
|
- |
|
Daly Richard J |
President and CEO |
|
2025-08-26 |
4 |
S |
$20.62 |
$473,641 |
D/D |
(22,970) |
226,794 |
|
-5% |
|
Daly Richard J |
President and CEO |
|
2025-08-26 |
4 |
OE |
$2.24 |
$112,000 |
D/D |
50,000 |
249,764 |
|
- |
|
Miller Steve |
Chief Op. & Scientific Officer |
|
2025-08-26 |
4 |
S |
$20.28 |
$2,332,200 |
D/D |
(115,000) |
949,663 |
|
-5% |
|
Miller Steve |
Chief Op. & Scientific Officer |
|
2025-08-26 |
4 |
OE |
$2.24 |
$257,600 |
D/D |
115,000 |
1,064,663 |
|
- |
|
Sundaram Preethi |
Chief Strategy Officer |
|
2025-06-11 |
4 |
S |
$26.42 |
$42,272 |
D/D |
(1,600) |
41,081 |
|
18% |
|
Sundaram Preethi |
Chief Strategy Officer |
|
2025-06-10 |
4 |
S |
$26.41 |
$61,377 |
D/D |
(2,324) |
42,681 |
|
21% |
|
Mcenany Patrick J |
Chairman of Board of Directors |
|
2025-06-09 |
4 |
S |
$26.11 |
$4,484,340 |
D/D |
(171,748) |
4,281,702 |
|
19% |
|
Mcenany Patrick J |
Chairman of Board of Directors |
|
2025-06-06 |
4 |
S |
$25.95 |
$732,998 |
D/D |
(28,252) |
4,453,450 |
|
19% |
|
Daly Richard J |
President and CEO |
|
2025-05-30 |
4 |
S |
$24.86 |
$1,740,200 |
D/D |
(70,000) |
199,764 |
|
17% |
|
Ingenito Gary |
Chief Med. & Reg. Officer |
|
2025-05-14 |
4 |
S |
$23.63 |
$1,039,720 |
D/D |
(44,000) |
68,873 |
|
15% |
|
Ingenito Gary |
Chief Med. & Reg. Officer |
|
2025-05-14 |
4 |
OE |
$4.64 |
$204,160 |
D/D |
44,000 |
112,873 |
|
- |
|
Ingenito Gary |
Chief Med. & Reg. Officer |
|
2025-05-13 |
4 |
S |
$23.68 |
$4,736,000 |
D/D |
(200,000) |
68,873 |
|
15% |
|
Ingenito Gary |
Chief Med. & Reg. Officer |
|
2025-05-13 |
4 |
OE |
$3.42 |
$684,000 |
D/D |
200,000 |
268,873 |
|
- |
|
Ingenito Gary |
Chief Med. & Reg. Officer |
|
2025-03-06 |
4 |
S |
$21.67 |
$3,902,680 |
D/D |
(180,096) |
68,873 |
|
2% |
|
Ingenito Gary |
Chief Med. & Reg. Officer |
|
2025-03-06 |
4 |
OE |
$2.24 |
$403,415 |
D/D |
180,096 |
248,969 |
|
- |
|
Ingenito Gary |
Chief Med. & Reg. Officer |
|
2025-03-05 |
4 |
S |
$22.09 |
$991,929 |
D/D |
(44,904) |
68,873 |
|
4% |
|
395 Records found
|
|
Page 1 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|